News World

Global Anti-obesity Drugs Market Research Report 2020

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Anti-obesity Drugs market.

Trusted Business Insights presents an updated and Latest Study on Anti-obesity Drugs Market 2020-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Anti-obesity Drugs market during the forecast period (2020-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Global Anti-obesity Drugs Market Research Report 2020

Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.

The global Anti-obesity Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Anti-obesity Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-obesity Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

  • Merck
  • Novo Nordisk
  • Pfizer
  • Arena Pharmaceuticals
  • Roche
  • GlaxoSmithKline
  • Orexigen Therapeutics
  • Vivus
  • Amylin
  • Alizyme
  • Boehringer Ingelheim
  • Eisai

Segment by Regions

  • North America
  • Europe
  • China
  • Japan

Segment by Type

  • Peripherally Acting Anti-obesity Drugs
  • Centrally Acting Anti-obesity Drugs

Segment by Application

  • Kids
  • Adults

In Aug 2020, Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Hanmi Pharmaceutical today announced that the companies have entered into an exclusive licensing agreement for the development, manufacture and commercialization of efinopegdutide (formerly HM12525A),Hanmis investigational once-weekly glucagon-like peptide-1 (GLP-1)/glucagon receptor dual agonist, for the treatment of nonalcoholic steatohepatitis (NASH).

Under the agreement, Merck will be granted an exclusive license to develop, manufacture and commercializeefinopegdutidein the United States and globally. Hanmi will receive an upfront payment of $10 million and is eligible to receive milestone payments up to $860 million associated with the development, regulatory approval and commercialization of efinopegdutide,as well as double-digit royalties on sales of approved product. Hanmi retains an option to commercialize efinopegdutide in Korea.

Efinopegdutide is a GLP-1/glucagon receptor dual agonist, which activates both the GLP-1 and glucagon receptors. The safety and efficacy of efinopegdutide has previously been evaluated in multiple Phase 1 and Phase 2 clinical trials, including for the treatment of severely obese individuals with and without type 2 diabetes mellitus.

Research Methodology: Global Metabolic Disorder Therapeutics Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.


Looking for more? Check out our repository for all available reports on Anti-obesity Drugs in related sectors.

Quick Read Table of Contents of this Report @ Global Anti-obesity Drugs Market Research Report 2020


Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580


Global Anti Obesity Drugs Market Statistical Analysis, COVID-19 Impact & Forecast 2020 – Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novo Nordisk

Anti Obesity Drugs Market 2020 Outlook, Analysis and COVID-19 Pandemic Impact Research Report Forecast to 2026

The COVID-19 outbreak is currently going the world over, this report covers the impact of the corona-virus on top growing companies in the Anti Obesity Drugs sector. This research report categorizes as the key vendors in the Anti Obesity Drugs market and also gives a comprehensive study of Covid-19 impact analysis of the market by type (Prescription Drugs, OTC drugs), application (Monotherapies, Polytherapies) and by regions like (Americas, APAC, and EMEA).

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, value chain, supply chain analysis, and Compounded Annual Growth Rate (CAGR) are interpreted in Syndicate Market Research study in a comprehensive manner. This rapidly changing market information can help readers understand the quantitative growth prospects of the Anti Obesity Drugs market during the forecast period.

To Get The Short-Term and Long-Term Impact Of COVID-19 On Anti Obesity Drugs Market | Get a Sample PDF Report, Please Visit:

**Note: The Final Report Will Be Updated To Address The Impact Of COVID-19 On This Particular Market. Use Only Corporate email ID to Get Higher Priority*

Structure of COVID-19 Impact Analysis on Anti Obesity Drugs Market

The report covers the present market scenario as well as imparts future growth prospects of the Anti Obesity Drugs market for the period between 2020 and 2029. The report also immerses key drivers, hindrances, opportunities and trends that are affecting the expansion of the global Anti Obesity Drugs market. It attempts a long-term picture of the global Anti Obesity Drugs market, in order to help businesses seeking opportunities for making investments in the worldwide market.

The report provides an exhaustive synopsis of the international Anti Obesity Drugs market report that provides an in-depth evaluation of a global and regional level. The market engulfing an executive summary, introduction and sizing that elucidates the core trends influencing the market expansion. This chapter also sheds light on the impacts that the dynamics are likely to pose on the growth of the market in the long run. The report also imparts figures appertaining to CAGRs from a historical and forecast point of view. An overview of the global Anti Obesity Drugs market follows the executive summary and issues a clear picture of the scope of the market to the report readers.

Competitive Landscape and Key Vendors

The Anti Obesity Drugs market is disintegrating and is highly competitive owing to the presence of major players and regional players. However, four major players dominate the market. All the dominant players are performing better than one another in one or two parameters and in this way, the competition in the Anti Obesity Drugs market is intensifying.

The Leading Vendors Included Inside The Reports Are:

Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eisai, Norgine, Arena Pharmaceuticals, Roche

Segmentation By Type and Analysis of The Anti Obesity Drugs Market

Prescription Drugs, OTC drugs

Segmentation By Application and Analysis of The Anti Obesity Drugs Market

Monotherapies, Polytherapies

Segmentation By Geography and Analysis of The Anti Obesity Drugs Market

• South America Anti Obesity Drugs Market Covers Colombia, Argentina and Brazil

• North America Anti Obesity Drugs Market Covers United States, Mexico and Canada

• Europe Anti Obesity Drugs Market Covers Germany, France, UK, Italy and Russia

• The Middle East and Africa Anti Obesity Drugs Market Covers UAE, Nigeria, South Africa, Saudi Arabia and Egypt

• Asia Pacific Anti Obesity Drugs Market Covers China, Japan, Southeast Asia, India and Korea


Any Questions? Feel Free To Enquire Here. We will Put You On The Right Path:

The Prime Objectives of Anti Obesity Drugs Market Report:

1. To scrutinize and research the global Anti Obesity Drugs status and future forecast hold, manufacturing production rate and ecosystem analysis, revenue, consumption, historical and forecast.

2. To present the key Anti Obesity Drugs manufacturers, SWOT analysis and development plans in the next few years.

3. To analyze the global and key region’s market potential and advantage, opportunity and challenge, restraints and risks.

4. To strategically analyze each submarket with respect to individual growth trend and their contribution to the Anti Obesity Drugs market.

5. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the Anti Obesity Drugs market.

In This Study, The Years Considered To Estimate The Market Size of Anti Obesity Drugs Market

History Year: 2016 to 2018

Estimated Year: 2019

Forecast Year: 2020-2026

Research Methodology Framework

Syndicate Market Research company based on the following procedures or techniques used to identify, select, process and analyze information about a Anti Obesity Drugs market. The experienced research professionals and consultant team have developed an exhaustive research methodology. Various parameters such as Macro-Economic Factors, Micro-Economic Factors, Technology and Innovation, Value Chain and market dynamics are evaluated for each market.

Data Extraction and Analysis

Data Extraction and Analysis is totally based on two main factors such as Data Synthesis (Collation of data, Estimation of key figures and Analysis of derived insights) and Data Validation (Triangulation with data models, Reference against proprietary databases and Corroboration with industry experts). Data is extracted at an extensive level from various relevant sources and repository of reports. Some of the secondary sources such as ICIS, Hoovers, Trade Magazines, Associations, Reuters and others are being used.

Global Market Forecasting

Global market forecasting used a modeling approach such as statistical techniques and forecasting. Both techniques are being used to estimate and forecast market data. Each regional market is evaluated separately.

Browse Complete Report Comprising In-depth Competitive Analysis At:

Key Questions Answered in Syndicate Market Research Report

1. Which grooming regions will continue to remain the most profitable regional markets for Anti Obesity Drugs market players?

2. Which circumstance will lead to a change in the demand for Anti Obesity Drugs during the assessment period?

3. How will change trends because of COVID-19 impact on the Anti Obesity Drugs market?

4. How can market players capture the low-hanging opportunities in the Anti Obesity Drugs market in developed regions?

5. What are the top winning strategies of stakeholders in the Anti Obesity Drugs market to upscale their position in this landscape?

Table of Contents:

1. Scope of the Report

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Syndicate Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2. Executive Summary

2.1 World Market Overview

2.1.1 Global Anti Obesity Drugs Consumption
2.1.2 Anti Obesity Drugs Consumption CAGR by Region

2.2 Anti Obesity Drugs Segment by Type
2.3 Consumption by Type
2.4 Segment by Application
2.5 Consumption by Application

3. Global Anti Obesity Drugs by Company

4. Anti Obesity Drugs by Geographical Segmentation

4.1 Americas Consumption Growth
4.2 APAC Consumption Growth
4.3 Europe Consumption Growth
4.4 The Middle East and Africa Anti Obesity Drugs Consumption Growth

5. Decision Framework

6. Appendix

List Of Abbreviations


To Identify The Key Trends In The Industry, Click On The Link Here:

Note – In order to provide a more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
(*If you have any special requirements, please let us know and we will offer you the report as you want.)

Why Go For Syndicate Market Research?

Setting a strong foot in the industry with all planned and tactical approaches is surely not a cakewalk. You need loads of research, analysis, consider several factors, and above all, give your valuable time to the entire process. This is where Syndicate Market Research kicks in as a support system for our clients.

Get in Touch with Us :

Syndicate Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
+1 347 535 0815 | Email ID: [email protected]


Anti-Obesity Drugs Booming Segments; Investors Seeking Growth

A New Syndicate COVID-19 Outbreak-Global Anti-Obesity Drugs Market Study is added in HTF MI database compiled covering key business segments and wider geographical scope to get deep dive analysed market data. The study brings a perfect bridging between qualitative and statistical data of COVID-19 Outbreak- Anti-Obesity Drugs market. The study provides historical data (i.e. Consumption** & Value) from 2014 to 2019 and forecasted till 2026*. Some are the key & emerging players that are part of coverage and have being profiled are Vivus, Rhythm Pharmaceuticals, F. Hoffmann La Roche, Shionogi USA, GlaxoSmithKline, Orexigen Therapeutics, FlaxoSithKline plc, Zafgen, Takeda Pharmaceutical, Alizyme, Novo Nordisk, Pfizer, Norgine Pharmaceuticals Ltd., Eisai Co, Ltd., BoehringerIngelheim GmbH & Bristol-Myers Squibb.

Know how you are perceived in comparison to your competitors like Vivus, Rhythm Pharmaceuticals, F. Hoffmann La Roche, Shionogi USA, GlaxoSmithKline, Orexigen Therapeutics, FlaxoSithKline plc, Zafgen, Takeda Pharmaceutical, Alizyme, Novo Nordisk, Pfizer, Norgine Pharmaceuticals Ltd., Eisai Co, Ltd., BoehringerIngelheim GmbH & Bristol-Myers Squibb; Get an accurate view of your business in COVID-19 Outbreak-Global Anti-Obesity Drugs Marketplace.

Click to get COVID-19 Outbreak-Global Anti-Obesity Drugs Market Research Sample PDF Copy Instantly

Market Dynamics:

Set of qualitative information that includes PESTEL Analysis, PORTER Five Forces Model, Value Chain Analysis and Macro Economic factors, Regulatory Framework along with Industry Background and Overview

Key Highlights that HTF MI is bringing with this Study
• Revenue splits by most promising business segments. [By Type (, Prescription Drugs & OTC Drugs), By Application (Men & Women) and any other business Segment if applicable within scope of report]
• Gap Analysis by Region. Country Level Break-up to dig out Trends and emerging opportunity available in area of your business interest.
• % Market Share & Sales Revenue by Key Players & Local Regional Players .
• Dedicated Section on Market Entropy to gain insights on Players aggressive Strategies to built market [Merger & Acquisition / Recent Funding & Investment and Key Developments]
• Patent Analysis** No of patents / Trademark approval filed & received in recent years.
• Competitive Landscape: Listed Players Company profile with SWOT, In-depth Overview, Product/Services Specification, Headquarter, Subsidiaries, Downstream Buyers and Upstream Suppliers.

Check Exclusive Discount Offers Available On this Report @

Competitive Landscape:

Mergers & Acquisitions, Agreements & Collaborations, New Product Launches, Business overview & detailed matrix of Product for each player listed in the study. Players exclusively profiled are Vivus, Rhythm Pharmaceuticals, F. Hoffmann La Roche, Shionogi USA, GlaxoSmithKline, Orexigen Therapeutics, FlaxoSithKline plc, Zafgen, Takeda Pharmaceutical, Alizyme, Novo Nordisk, Pfizer, Norgine Pharmaceuticals Ltd., Eisai Co, Ltd., BoehringerIngelheim GmbH & Bristol-Myers Squibb

Most frequently asked question:
Why i can’t See My company Profiled in the Study?
Yes, It might be a possibility that Company you are looking for is not listed, however study is based on vast coverage of players operating in but due to limited scope and pricing constraints we can only list few random companies keeping a mix of leaders and emerging players. Do contact us if you wish to see any specific company of your interest in the survey. Currently list of companies available in the study are Vivus, Rhythm Pharmaceuticals, F. Hoffmann La Roche, Shionogi USA, GlaxoSmithKline, Orexigen Therapeutics, FlaxoSithKline plc, Zafgen, Takeda Pharmaceutical, Alizyme, Novo Nordisk, Pfizer, Norgine Pharmaceuticals Ltd., Eisai Co, Ltd., BoehringerIngelheim GmbH & Bristol-Myers Squibb

Segment & Regional Analysis: What Market breakdown Would be Covered by geographies, Type & Application/End-users
• COVID-19 Outbreak- Anti-Obesity Drugs Market Revenue & Growth Rate by Type [, Prescription Drugs & OTC Drugs] (Historical & Forecast)
• COVID-19 Outbreak-Global Anti-Obesity Drugs Market Revenue & Growth Rate by Application [Men & Women] (Historical & Forecast)
• COVID-19 Outbreak- Anti-Obesity Drugs Market Revenue & Growth Rate by Each Region Specified (Historical & Forecast)
• COVID-19 Outbreak- Anti-Obesity Drugs Market Volume & Growth Rate by Each Region Specified, Application & Type (Historical & Forecast)
• COVID-19 Outbreak- Anti-Obesity Drugs Market Revenue, Volume & Y-O-Y Growth Rate by Players (Base Year)

Enquire for customization in Report @

To comprehend COVID-19 Outbreak-Global Anti-Obesity Drugs market dynamics in the world mainly, the worldwide COVID-19 Outbreak- Anti-Obesity Drugs market is analyzed across major global regions. HTF also provides customized regional and country-level reports

• North America: United States, Canada, and Mexico.
• South & Central America: Argentina, Chile, Colombia and Brazil.
• Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt, Tunisia and South Africa.
• Europe: United Kingdom, France, Poland, Italy, Germany, Spain, NORDIC {Sweden, Norway, Finland, Denmark etc}, BENELUX {Belgium, The Netherlands, Luxembourg },and Russia.
• Asia-Pacific: SAARC Nations, China, Japan, South Korea, Southeast Asia, New Zealand & Australia.

Actual Numbers & In-Depth Analysis with emerging trends of COVID-19 Outbreak- Anti-Obesity Drugs Market Size Estimation Available in Full Copy of Report.

Buy Full Copy of COVID-19 Outbreak-Global Anti-Obesity Drugs Market Latest Released Edition

Thanks for reading this article, you can also get individual chapter or section or regional study by limiting the scope to just G7 or G20 or European Union Countries, Eastern Europe, East Asia or Southeast Asia.

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
[email protected]

Connect with us at LinkedIn | Facebook | Twitter